Although both anidulafungin and micafungin are approved for treatment of candidiasis, their role in invasive aspergillosis requires more clinical trial evaluation.

• 虽然阿尼芬净和米卡芬净已批准用于念珠菌感染的治疗，它们在侵袭性曲霉菌病治疗中的作用还需要更多的临床试验来评价。